b'NotesWarranty and Liability LimitsInvivoscribe, Inc (Invivoscribe) is committed to providing the highest quality products. Invivoscribe warrants that the products meet or exceed the performance standards described in the Instructions For Use, as to products with such an insert. If a product is covered by product specifications and does not perform as specified, our policy is to replace the product or credit the full purchase price. No other warranties of any kind, expressed or implied, are provided by Invivoscribe. Invivoscribe liability shall not exceed the purchase price of the product. Invivoscribe shall have no liability for direct, indirect, consequential or incidental damages arising from the use, results of use, or inability to use its products; product efficacy under purchaser controlled conditions in purchasers laboratory must be established and continually monitored through purchaser defined and controlled processes including but not limited to testing of positive, negative, and blank controls every time a sample is tested. Ordering, acceptance and use of product constitutes purchaser acceptance of sole responsibility for assuring product efficacy and purchaser agreement to the limitation of liability set forth in this paragraph.Intended UsesResearch Use Only products have not been approved by any regulatory agency for clinical use and are not for diagnostic or therapeutic use. Our CE-marked IdentiClone assays, sold in Europe and not for sale or use in the United States, are in vitro Diagnostic devices intended for detection of clonal gene rearrangements and translocations for patients with suspected lymphoproliferations.Patent NoticeMany of the products described herein are covered by one or more of the following: European Patent Number 1549764, European Patent Number 2418287, European Patent Number 2460889, Japanese Patent Number 4708029, United States Patent No. 7,785,783, United States Patent 8859748, United States Patent 10280462, additional United States Patents Pending and planned future applications. All of these patents and applications are licensed exclusively to Invivoscribe. Additional patents licensed to Invivoscribe covering some of these products apply elsewhere, or as described in this catalog.Use of these products may require nucleic acid amplification methods such as Polymerase Chain Reaction (PCR). Any necessary license to practice amplification methods or to use amplification enzymes or equipment covered by third party patents is the responsibility of the user and no such license is granted by Invivoscribe, expressly or by implication.Notice2020 Invivoscribe, Inc. All rights reserved. The trademarks mentioned herein are the property of Invivoscribe, and/or its affiliates, or (as to the trademarks of others used herein) their respective owners.ILLUMINA and MISEQ are registered trademarks of Illumina, Inc. THERMO FISHER SCIENTIFIC and ION PGM and ION S5 are trademarks of Thermo Fisher Scientific or its subsidiaries.AGILENT and BIOANALYZER are registered trademarks of Agilent Technologies, Inc.KAPA is a trademark of Kapa Biosystems.PERKIN ELMER and LABCHIP are registered trademark of Perkin Elmer.MICROSOFT, WINDOWS, and EXCEL are registered trademarks of Microsoft Corporation.Roche is a registered trademark of F. Hoffmann-La Roche Ltd.Invivoscribe 2020|169'